Skip to main content

Table 1 General information of patients

From: Application of metagenomic next-generation sequencing in the clinical diagnosis of infectious diseases after allo-HSCT: a single-center analysis

 

Patients with allo-HSCT (n = 54)

Age (years)

40 (7–68)

Sex (male/female)

39/15

Temperature (°C)

38.45 (36.5–40.7)

Laboratory tests

 CRP (mg/L)

51.8 (4-528)

 IL-6 (pg/mL)

21.6 (0.08–5001)

 PCT (µg/L)

0.11 (0.01–80.41)

 WBC (×109/L)

4.43 (0.01–19.60)

Abnormal lung imaging (%)

49(90.7)

Disease type (%)

 AML

27(50%)

 ALL

14(25.9%)

 MDS

6(11.1%)

 AA

3(5.6%)

 CMML

4(7.4%)

HSCT type (%)

MAC-Haplo-HSCT

49(90.7%)

RIC-Haplo-HSCT

3(5.6%)

MAC-MSD-HSCT

2(3.7%)

  1. CRP C-reactive protein, IL-6 Interleukin-6, PCT Procalcitonin, WBC White blood cell, HSCT Hematopoietic stem cell transplantation, MAC-Haplo-HSCT Myeloablative Haploidentical hematopoietic stem cell transplantation, RIC-Haplo-HSCT Reduced-intensity conditioning haploidentical hematopoietic stem cell transplantation, MAC-MSD-HSCT Myeloablative matched-sibling donors hematopoietic stem cell transplantation, allo-HSCT Allogeneic hematopoietic stem cell transplantation, ALL Acute lymphoblastic leukemia, CMML Chronic myelomonocytic leukemia, MDS Myelodysplastic syndrome, AA Aplastic anemia